Stoke Therapeutics and Xenon Pharmaceuticals Join Founders BioMarin and Invitae to Offer a No-Cost Epilepsy Gene Panel Testing Program for Children Up to 60 Months Who Have Had an Unprovoked… Read More
VANCOUVER, BC – Life Sciences BC is pleased to announce the recipients of the 21st Annual Life Sciences BC Awards, presented by FARRIS. These awards are presented annually to recognize… Read More
VANCOUVER, BC and SAN DIEGO, CA. – Phoenix Molecular Designs (PhoenixMD), a privately-held biotechnology company designing precise cancer therapeutics by targeting essential kinases, announced today that Dr. Sandra Dunn, PhoenixMD’s Chief Executive Officer, will… Read More
Complete Response Rate of 42% as Assessed by Principal Investigator Supports VAL-082’s Activity in GBM VANCOUVER, British Columbia and MENLO PARK, Calif., Feb. 20, 2019 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI)… Read More
GenXys, a precision prescribing software company tackling a $130 billion global problem, is pleased to announce that it has closed its oversubscribed seed round at $1.77 million, with key investors… Read More
